Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Issues Quarterly Earnings Results

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) announced its earnings results on Monday. The company reported ($0.03) EPS for the quarter, Zacks reports.

Greenland Mines Ltd. Common Stock Stock Performance

Shares of NASDAQ:GRML traded down $0.00 during midday trading on Monday, reaching $0.20. 4,760,030 shares of the company’s stock traded hands, compared to its average volume of 4,195,405. Greenland Mines Ltd. Common Stock has a one year low of $0.16 and a one year high of $0.95. The stock has a 50 day moving average of $0.23 and a 200 day moving average of $0.36. The company has a market cap of $27.52 million, a price-to-earnings ratio of -0.62 and a beta of 7.13.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Weiss Ratings lowered shares of Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. Wall Street Zen raised Greenland Mines Ltd. Common Stock to a “sell” rating in a report on Saturday, May 2nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Insider Activity

In other news, Director Riad Hussein El-Dada sold 175,000 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $0.23, for a total transaction of $40,250.00. Following the sale, the director owned 175,000 shares of the company’s stock, valued at $40,250. This trade represents a 50.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jason David Sawyer purchased 240,000 shares of Greenland Mines Ltd. Common Stock stock in a transaction dated Wednesday, July 22nd. The stock was bought at an average price of $0.23 per share, with a total value of $55,200.00. Following the completion of the purchase, the director directly owned 240,000 shares of the company’s stock, valued at approximately $55,200. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 11.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

Several hedge funds and other institutional investors have recently modified their holdings of GRML. Jane Street Group LLC bought a new stake in shares of Greenland Mines Ltd. Common Stock in the second quarter worth $26,000. Geode Capital Management LLC lifted its holdings in Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after acquiring an additional 167,905 shares during the period. Renaissance Technologies LLC bought a new position in Greenland Mines Ltd. Common Stock in the fourth quarter valued at about $126,000. Finally, XTX Topco Ltd boosted its position in Greenland Mines Ltd. Common Stock by 101.2% in the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after purchasing an additional 80,768 shares during the last quarter. 20.07% of the stock is owned by institutional investors.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.